Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cronos Group Inc CRON


Primary Symbol: T.CRON

Healthcare Cannabis
Cronos Group Inc. is a Canada-based global cannabinoid company engaged in building intellectual property by advancing cannabis research, technology and product development. The Company operates through one segment, which is comprised of operations in Canada and Israel and is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and... see more

Recent & Breaking News (TSX:CRON)

Cronos Group (TSX:CRON) partners with Geocann

Shoran Devi June 27, 2022

Cronos Group Partners with Geocann to Leverage VESIsorb® Delivery Technology for Faster Absorption

GlobeNewswire June 27, 2022

Cronos Group Inc. Announces Results of 2022 Annual Meeting of Shareholders

GlobeNewswire June 24, 2022

Cronos Group and Ginkgo Bioworks Announce Achievement of THCV Equity Milestone

GlobeNewswire June 21, 2022

Cronos Group Inc. Announces Conference Participation for May 2022

GlobeNewswire May 10, 2022

Cronos Group Reports 2022 First Quarter Results

GlobeNewswire May 10, 2022

Cronos Group Inc. to Hold Virtual 2022 Annual Meeting of Shareholders

GlobeNewswire April 29, 2022

Cronos Group Inc. to Hold 2022 First Quarter Earnings Conference Call on May 10, 2022

GlobeNewswire April 25, 2022

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Cronos Group Inc. Investors to Inquire About Class Action Investigation - CRON

Business Wire April 5, 2022

Cronos Group Founder Returns as CEO

Trevor Abes  March 21, 2022

Cronos Group Founder Mike Gorenstein Returns as CEO

GlobeNewswire March 21, 2022

Cronos Group Reports 2021 Fourth Quarter and Full-Year Results

GlobeNewswire March 1, 2022

Cronos Group Inc. to Hold 2021 Fourth Quarter and Full-Year Earnings Conference Call on March 1, 2022

GlobeNewswire February 25, 2022

Lost Money in Cronos Group, Inc.?

Business Wire February 18, 2022

Cronos Group Reports 2021 Third Quarter Results

GlobeNewswire February 18, 2022

Cronos Group Inc. to Hold 2021 Third Quarter Earnings Conference Call on February 18, 2022

GlobeNewswire February 17, 2022

Lost Money in Cronos Group, Inc.?

Business Wire February 14, 2022

Cronos Group Provides Bi-Weekly MCTO Status Update

GlobeNewswire February 11, 2022

Cronos Group Provides Bi-Weekly MCTO Status Update

GlobeNewswire January 28, 2022

Cronos Group Provides Bi-Weekly MCTO Status Update

GlobeNewswire January 14, 2022